NCT00651963View on ClinicalTrials.gov

Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Lipid Metabolism Disorder
Interventions
DRUG

ezetimibe

"Ezetimibe 10 mg daily was added during 4 weeks.~The patients continued taking their usual Statin without titrating the dose."

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00651963 - Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED) | Biotech Hunter | Biotech Hunter